9.330
−1,79%
2026-10-19
Fundamental Analysis
43 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -4.0% | +7.4% | 2 / 3 | +2.5% | +4.56 pp | +1.72 pp | +5.8% | 1.37 | 8.04 | 970 | +2,5% | 172 | +13,5% | 8.04 | 12.37 | −35,0% |
| Pts | 0 | 0 | 8 | 0 | 12 | 8 | 0 | 6 | 12 | |||||||
Valuation annotation:Price: 9.330 (close price on 2026-10-19)EPS (TTM): 1.160
Financial charts
1.Revenue & growth
VND bn970Q2/26
1.Revenue & growth
VND bn970Q2/26
2.Profit & growth
VND bn145Q2/26
3.Profit mix (Penman)
VND bn847Q2/26
4.Margins & cost structure
%45.0%Q2/26
5.Returns & cash cycle
% · days5.0%Q2/26
6.Earnings quality & cash
VND bn2.105Q2/26
7.Asset structure
VND bn41.116Q2/26
8.Funding & debt health
VND bn · times41.116Q2/26
9.Revenue backlog
VND bn761Q2/26
10.Valuation
times · %8,5×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %265Q2/26
Adjusted EPS growth, latest quarter
0.8%
Average adjusted EPS growth, 3 quarters
13.1%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
10.0%
Source: vnstockData through Q2/26